Patent · US Active

Manufacture of factor H (FH) and FH-derivatives from plasma

US8822656B2 · kind B2 · utility

0Cited by

1References

22Claims

0Family size

Assignees

Baxter International Inc. · US
Baxter Healthcare SA · CH

Inventors

Shawn F. Bairstow · Gurnee, US
Richard J. Johnson · Colville, US
Sindhu Ramachandran · Lake Zurich, US
Ruth Madlener · Wien, AT
Wolfgang Teschner · Wien, AT
Hans-Peter Schwarz · Wien, AT

Key dates

Filing date	Mar 14, 2013
Grant date	Sep 2, 2014
Priority date	—
Expiry date	Mar 14, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K1/36
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compositions and pharmaceutical formulations of Factor H derived from plasma. Also provided are methods for the manufacture of the Factor H compositions and formulations, as well as methods for the treatment of diseases associated with Factor H dysfunction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.